Clinical Trial Update: Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage [NA]

View source ↗

Summary

Clinical trial evaluating intravenous immunoglobulin (IVIG) for unexplained secondary recurrent miscarriage; results have been posted for a completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Habitual Abortion
• Miscarriage

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: University of Chicago | Conditions: Miscarriage, Recurrent, Abortion, Habitual | NA | Status: COMPLETED | Results posted: 2010-08-30